The Business Times

Gilead

Consumer & Healthcare

Gilead's remdesivir gets US FDA approval for hospitalised Covid-19 patients

Gilead questions WHO study that cast doubts on drug's Covid-19 benefits
Consumer & Healthcare

Gilead questions WHO study that cast doubts on drug's Covid-19 benefits

Europe buys Gilead's remdesivir for 500,000 Covid-19 patients amid supply worries
International

Europe buys Gilead's remdesivir for 500,000 Covid-19 patients amid supply worries

Gilead to buy cancer drugmaker Immunomedics for US$21b
Consumer & Healthcare

Gilead to buy cancer drugmaker Immunomedics for US$21b

Gilead says additional data on remdesivir shows improved Covid-19 clinical recovery
Consumer & Healthcare

Gilead says additional data on remdesivir shows improved Covid-19 clinical recovery

Australia approves Gilead's remdesivir for Covid-19 treatment
International

Australia approves Gilead's remdesivir for Covid-19 treatment

Gilead's Covid-19 antiviral remdesivir gets conditional EU clearance
Consumer & Healthcare

Gilead's Covid-19 antiviral remdesivir gets conditional EU clearance

Covid-19 drug to cost government entities US$2,340 for 5-day course
International

Covid-19 drug to cost government entities US$2,340 for 5-day course

Gilead's remdesivir endorsed as first Covid-19 treatment in Europe
Consumer & Healthcare

Gilead's remdesivir endorsed as first Covid-19 treatment in Europe

Gilead targets remdesivir supply for 2 million Covid-19 patients by year-end
Consumer & Healthcare

Gilead targets remdesivir supply for 2 million Covid-19 patients by year-end

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More